Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnWeb3SquareMore
Trade
Spot
Buy and sell crypto with ease
Margin
Amplify your capital and maximize fund efficiency
Onchain
Going Onchain, without going Onchain!
Convert
Zero fees, no slippage
Explore
Launchhub
Gain the edge early and start winning
Copy
Copy elite trader with one click
Bots
Simple, fast, and reliable AI trading bot
Trade
USDT-M Futures
Futures settled in USDT
USDC-M Futures
Futures settled in USDC
Coin-M Futures
Futures settled in cryptocurrencies
Explore
Futures guide
A beginner-to-advanced journey in futures trading
Futures promotions
Generous rewards await
Overview
A variety of products to grow your assets
Simple Earn
Deposit and withdraw anytime to earn flexible returns with zero risk
On-chain Earn
Earn profits daily without risking principal
Structured Earn
Robust financial innovation to navigate market swings
VIP and Wealth Management
Premium services for smart wealth management
Loans
Flexible borrowing with high fund security
Bio Protocol on DeSci and the future of DAOs

Bio Protocol on DeSci and the future of DAOs

The BlockThe Block2025/02/24 16:00
By:By Jordan Leech

Quick Take Bio Protocol Co-Founder and CEO Paul Kohlhaas joined The Crypto Beat to shed light on the current state of DeSci, and how his firm is looking to utilize blockchain technology to reshape science funding.

Bio Protocol on DeSci and the future of DAOs image 0

Episode 16 of The Crypto Beat was recorded with The Block's Editor-In-Chief Tim Copeland and Bio Protocol Co-Founder and CEO Paul Kohlhaas.

Listen below, and subscribe to The Crypto Beat on YouTube ,  Apple ,  Spotify , Twitch, or wherever you listen to podcasts. Please send feedback and revision requests to  [email protected]

The Block's Editor-in-Chief, Tim Copeland, was joined by Bio Protocol Co-Founder and CEO Paul Kohlhaas.

In this episode, Copeland and Kohlhaas discussed the concept of decentralized science (DeSci) and how Bio Protocol is using blockchain technology to decentralize scientific research and funding.

OUTLINE
00:00 Introduction and understanding DeSci
05:39
The typical DeSci participant
10:42
Regulatory concerns
13:29 How Bio works
18:22 Value accrual for Bio
24:25 The role of tokens
32:13 DeSci as the next meta?
43:15 Binance and CZ
47:01 Responsibility in DeSci
50:26 Paul’s entry into crypto
56:04 Conclusion

The Block Newsletters

The Block's newsletters bring you the latest news and analysis of the fast-moving crypto and DeFi markets. To subscribe, visit theblock.co/newsletters

Guest links:
Paul Kohlhaas - https://www.linkedin.com/in/kohlhaas/
Paul Kohlhaas on X - https://x.com/paulkhls/

Bio Protocol - https://www.bio.xyz/
Bio Protocol on X - https://x.com/bioprotocol


0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

Navigating the $15B Bitcoin Options Expiry: Strategic Entry and Risk Management in a Volatile Market

- The Aug 29, 2025 Bitcoin options expiry involves $11.6–$14.6B in notional value, creating a volatile battleground between institutional and retail traders. - A 1.31 put/call ratio and $116,000 max pain level suggest bearish bias, but liquidity providers may push prices toward this level to minimize losses. - Institutional hedging via inverse ETFs and macroeconomic factors like inflation and Fed policy add complexity, balancing technical signals with broader market dynamics. - Strategic options like contr

ainvest2025/08/29 17:00
Navigating the $15B Bitcoin Options Expiry: Strategic Entry and Risk Management in a Volatile Market

17 Listed Companies Hold 3.4 Million ETH, Institutional Ethereum Holdings Reach Record High in Q2

The holdings of investment advisory firms far exceed those of other types of institutions.

区块链骑士2025/08/29 16:53
17 Listed Companies Hold 3.4 Million ETH, Institutional Ethereum Holdings Reach Record High in Q2